Results 261 to 270 of about 61,167 (344)

Misdiagnosis of occult heterotopic intramural ectopic pregnancy by two-dimensional ultrasound: Two case reports. [PDF]

Front Med (Lausanne)
Zhang J, Dong Z, Guo S, Ma H, Huang B.
europepmc   +1 more source

Diagnosis and classification of uterine fibroids. [PDF]

Int J Gynaecol Obstet
Lakabi R, Harth S, Meinhold-Heerlein I, Olsthoorn AV, Munro MG, Murji A.   +5 more
europepmc   +1 more source

Shaoyao gancao decoction induces autophagy by modulating miR-21 and inhibiting the AKT/mTOR signaling pathway in adenomyosis-derived ectopic endometrial stromal cells. [PDF]

Front Pharmacol
Lai H, Jia J, Kuang Z, Lu J, Zeng Y.
europepmc   +1 more source

Case Report: Preoperative ultrasonographic diagnosis of accessory cavitated uterine malformation: a case series report and narrative review. [PDF]

Front Oncol
Shen T, Yuan H, Cao H, Liu J, Duan X, Chen S, Tian R, Duan X.   +7 more
europepmc   +1 more source

Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling.

J Clin Endocrinol Metab
Malcom C, Guzeloglu-Kayisli O, Un B, New E, Cetinkaya-Un B, Guo X, Mikhail E, Imudia A, Lockwood C, Kayisli U.   +9 more
europepmc   +1 more source

M1 Macrophages Are a Source of IL-1α: A Driver of Progesterone Metabolism and Myometrial Contraction. [PDF]

Cells
Nadeem L, Librach M, Boros-Rausch A, Matthews B, Aguiar-Cabeza E, Shynlova O, Lye SJ.   +6 more
europepmc   +1 more source

Spatially Mapping the Mechanical and Structural Properties of the Seedling Uterine Fibroid-Myometrium Interface

Daniella M. Fodera, Alara Sutcu, Arielle S. Joasil, Aidan M. Therien, Johanna L. L. Jackson, Arnold P. Advincula, Xiaowei Chen, Christine P. Hendon, Michelle L. Oyen, Tal Korem, Kristin M. Myers   +10 more
openalex   +1 more source

Glycolytic Reprogramming in Uterine Fibroids: Genetic, Transcriptomic, Proteomic, and Metabolomic Insights. [PDF]

Genes (Basel)
El Sayed S, Pan A, Vanos V, Michel R, Borahay M.   +4 more
europepmc   +1 more source

Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma. [PDF]

BMC Cancer
Toyohara Y, Sone K, Kumegawa K, Yamamoto Y, Hachijo R, Kukita A, Taguchi A, Ikemura M, Miyamoto Y, Tanikawa M, Iriyama T, Mori M, Hamamoto R, Ushiku T, Oda K, Hirota Y, Maruyama R, Osuga Y.   +17 more
europepmc   +1 more source